High Praise for Thermo Fisher: Doing What is Necessary
“It is no use saying, ‘We are doing our best.’ You have got to succeed in doing what is necessary.” Sir Winston Churchill
Thermo Fisher Scientific, based in Waltham, Mass and the largest maker of scientific tools, announced this past Friday that their new diagnostic test can be used immediately to detect the virus causing COVID-19, a dramatic and an invaluable advancement in stemming the spread of the coronavirus.
“Agnew Multilingual is glad to have Thermo Fisher as our partner and congratulate them for their quick action in view of Covid-19,” said Irene Agnew, company president. A sentiment shared by President Trump, who in a national address stated, “I’d also like to thank Thermo Fisher. The FDA’s goal is to hopefully authorize their application within 24 hours — it’ll go very quickly; it’s going very quickly — which will bring, additionally, 1.4 million tests on board next week and 5 million within a month.” Added an administration official, “this will dramatically increase our ability to test people for the virus.”
Now that the Food and Drug Administration has in fact granted this emergency clearance, Thermo Fisher plans to more than double production, scaling from the current 2 million tests per week to 5 million tests per week, reaching this level of production by the week of April 3, according to Ron O’Brien, a company spokesman. “Effectively, the entire organization of 75,000 employees is involved in our response,” O’Brien said.
Enabling our clients to do “what is necessary” is a cornerstone of Agnew Multilingual’s commitment to excellence and service. We are available, without disruption, to provide translation assistance during these most challenging times. How can we be of service?